Pediatrix Medical MD
- Market cap
- $2.4B
- PE
- 16.7×
- 10y median 13.4×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.2×
- EV/EBIT
- 12.0×
- Revenue, 12 months
- $2B
- +2% on a year ago
- Net margin
- 7.7%
- Free cash flow yield
- 8.7%
Pediatrix Medical trades at 16.7× trailing earnings, pricier than 69% of the last ten years. Revenue was $2B over the last twelve months, up 2% on a year earlier with a 8% net margin.
Charts
Financials
| Income statement | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $496.4M−3% | $495.1M+1% | $504.3M+1% | $511.2M+1% | $502.4M+1% | $458.4M−7% | $468.8M−7% | $492.9M−4% | $493.8M−2% | $476.2M+4% | $487.8M+4% | $501.4M+2% | |
| SG&A | $53.1M+4% | $60.2M+2% | $56.6M−3% | $58.1M+1% | $63.6M+20% | $58.6M−3% | $55.7M−2% | $60.8M+5% | $65.7M+3% | $60.3M+3% | $61.3M+10% | $62.7M+3% |
| −$111.5M | $15.9M−47% | −$157.7M | $33.8M−16% | $39.3M | $32.1M+102% | $59.9M | $68.1M+101% | $48.8M+24% | $41.7M+30% | $56.9M−5% | $65.2M−4% | |
| Interest expense | $10.1M+1% | $10.6M+2% | $10.3M−8% | $10.1M−2% | $9.7M−4% | $9.2M−14% | $9.1M−11% | $8.9M−12% | $8.7M−10% | $8.3M−10% | $8.2M−11% | $8.1M−9% |
| Pre-tax income | −$138.8M | $7.8M−62% | −$167.7M | $25.2M−18% | $33.3M | $28.1M+259% | $55M | $87.8M+248% | $45.6M+37% | $38.8M+38% | $54M−2% | $65M−26% |
| −$14.6M | $3.8M−42% | −$14.7M | $5.8M−39% | $2.8M | $7.4M+94% | $15.7M | $16.1M+177% | $11.9M+318% | $9.3M+26% | $14.2M−10% | $18M+12% | |
| Net income | −$124.3M | $4M−72% | −$153M | $19.4M−9% | $30.5M | $20.7M+414% | $39.3M | $71.7M+269% | $33.7M+11% | $29.6M+43% | $39.8M+2% | $47M−35% |
| −$1.51 | $0.05−71% | −$1.84 | $0.23−12% | $0.36 | $0.24+380% | $0.46 | $0.84+265% | $0.40+11% | $0.36+50% | $0.49+7% | $0.59−30% | |
| 82.4M+1% | 83.3M+1% | 83.3M+1% | 84.5M+2% | 83.6M+2% | 85.4M+3% | 85.5M+3% | 85.6M+1% | 84.4M+1% | 83.1M−3% | 81.4M−5% | 79.7M−7% |
EPS, diluted: 8 periods, Q2 FY09 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 5 periods, Q4 FY09 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY23: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Medical - Care Facilities nearest Pediatrix Medical's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| MDPediatrix Medical | $2.4B | 16.7× | 13.4× | 1.2× | +2% | 7.7% | |
| ADUSAddus HomeCare | $2.3B | 22.1× | 32.4× | 1.6× | +16% | 7.1% | |
| PGNYProgyny | $2.3B | 32.0× | 54.7× | 1.7× | +6% | 6.0% | |
| PRVAPrivia Health | $2.7B | 101× | 157× | 1.2× | +24% | 1.2% | |
| AVAHAveanna Healthcare | $2.9B | 10.7× | 21.4× | 1.1× | +20% | 10.6% | |
| NHCNational Healthcare | $3.2B | 22.7× | 21.4× | 2.0× | +7% | 9.0% | |
| HCSGHealthcare Services | $1.7B | 17.3× | 26.1× | 0.9× | +4% | 5.6% | |
| ARDTArdent Health | $1.7B | 21.3× | 8.5× | 0.3× | +3% | 1.2% | |
| PNTGPennant | $1.4B | 45.0× | 46.5× | 1.3× | +38% | 2.9% | |
| USPHU S Physical Therapy | $1.3B | 96.5× | 42.1× | 1.6× | +11% | 4.0% | |
| OPCHOption Care Health | $4.7B | 23.8× | 26.4× | 0.8× | +6% | 3.7% | |
| Peer median | $2.3B | 23.3× | 29.4× | 1.2× | +9% | 4.8% |
More on Pediatrix Medical
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #8of 32Hospital and care facility stocks with the highest free cash flow yield
- #8of 27Hospital and care facility stocks with the lowest PE ratio
- #10of 31Hospital and care facility stocks with the lowest EV/EBIT
- #9of 11Hospital and care facility stocks cheapest against their own PE history
Its groups
About
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .